During the past decade, Maple Leaf Research conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 8 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Maple Leaf Research" #1 collaborator was "CIHR Canadian HIV Trials Network" with 1 trials as a collaborator, "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator and "Gilead Sciences" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Maple Leaf Research" are "HIV Infections" (6 trials), "HIV-1 Infection" (5 trials), "HIV" (3 trials), "HIV-1-infection" (2 trials) and "Acquired Immunodeficiency Syndrome" (1 trials). Many other conditions were trialed in "Maple Leaf Research" in a lesser frequency.

Most popular intervention types in "Maple Leaf Research" are "Drug" (12 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "E/C/F/TAF" (4 trials), "E/C/F/TDF" (3 trials), "B/F/TAF" (2 trials), "E/C/F/TAF Placebo" (2 trials) and "E/C/F/TDF Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Maple Leaf Research" are 12 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Maple Leaf Research". 1 are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Maple Leaf Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Maple Leaf Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".